No Data
Tianjin Pharmaceutical Da Ren Tang Group Appoints Chair
TJ Darentang USD: Wang Lei replaces Zhang Mingrui as the chairman, the company's development global strategy "will not change" | Speed reading announcement
① Zhang Mingrui applied to resign as the chairman, director, and chairman of the global strategy committee of tj darentang usd due to work changes. ② Wang Lei, the general manager, took over as chairman, with company officials stating that the enterprise development strategy "will not change".
tj darentang (600329.SH): Elected director Wang Lei as the chairman of the company.
Gelonghui November 26th | tj darentang usd (600329.SH) announced that Ms. Zhang Mingrui submitted a written resignation. Due to job changes, Ms. Zhang Mingrui applied to resign from the positions of company director, director, and chairman of the board of directors. After resigning, Ms. Zhang Mingrui will no longer hold any position in the company. After the nomination and review by the board of directors' nominating committee, the meeting approved the "election of Ms. Wang Lei as the company's chairman of the board of directors." According to the company's articles of association, the company's legal representative has changed to Ms. Wang Lei.
tj darentang plans to sell 13% of its stake in China and America Shire, pending antitrust review | Directly hitting the shareholder meeting.
At today's tj darentang shareholder meeting, the proposal to sell 13% equity of China-US Tianjin Shexi Pharmaceutical Co., Ltd. (referred to as China-US Shexi) to Heiliong was approved. Company chairman Zhang Mingrui said: "China-US Shexi is an excellent company, and the main reason for this equity sale is the expiration of the 40-year cooperation period." This equity sale still needs to be reviewed for anti-monopoly by the State Administration for Market Regulation on Heiliong's side.
tj darentang usd (600329) 2024 third-quarter report review: Industrial steady running, sailing marketing 2.0.
Items: The company announced that the revenue, net profit attributable to mother, and non-recurring net profit for the first three quarters of 24 were 561 million, 0.8 million, and 0.77 billion yuan, respectively, with year-on-year changes of -3.1%, -6.3%, -8.9%. Among them, 3Q24 revenue, net profit attributable to mother,
tj darentang usd (600329): Industrial steady growth, commercial is being divested.
Investment highlights: tj darentang usd released the third quarter report of 2024, achieving revenue of 5.611 billion yuan (-3.14% year-on-year), net income attributable to mother of 0.804 billion yuan (-6.33% year-on-year), non-net profit attributable to mother of 7.
No Data
No Data